Proximagen Group's P2P Acquisition

Proximagen Group raised a round of funding on August 14, 2012. Investors include Upsher-Smith Laboratories.

Proximagen Group (AIM: PRX) is a biotechnology company focused on the development and commercialization of therapeutics for diseases of the central nervous system and inflammation.…

Articles about Proximagen Group's P2P Acquisition: